Head to head, fairly
Side-by-side looks at the GLP-1 medications, always with the question that matters for the off-ramp: which loss can you keep? These pages never tell you which drug to take; that is a clinician decision.
- Semaglutide vs semaglutide
Ozempic vs Wegovy
Ozempic and Wegovy are both semaglutide. The real differences are approved use, dosing, and coverage, plus what happens to your weight when you stop either one.
Compare → - Single vs dual agonist
Semaglutide vs Tirzepatide
Semaglutide (Ozempic, Wegovy) vs tirzepatide (Mounjaro, Zepbound): mechanism, average weight loss, side effects, and the off-ramp difference that decides whether the loss lasts.
Compare → - Tirzepatide vs tirzepatide
Zepbound vs Mounjaro
Zepbound and Mounjaro are both tirzepatide. The difference is approved use (obesity vs diabetes), and the maintenance principles after stopping are identical.
Compare → - Liraglutide vs semaglutide
Saxenda vs Ozempic
Saxenda (liraglutide, daily) vs Ozempic (semaglutide, weekly): dosing frequency, average weight loss, and what the regain data shows for each after stopping.
Compare →